- January 22, 2020
- Category: Healthcare and LifeSciences, Medical Diagnostics
Global Coagulation Analyzer Market Size study, by Product (Clinical Laboratory, consumables, reagents, PoCT, Manual, Automated), Test (Prothrombin Time Testing (PT), Fibrinogen, APTT, Activated Clotting Time Testing (ACT), Activated Partial Thromboplastin Time Testing, D Dimer, Platelet Function Tests, Anti-Factor XA Tests, Heparin & Protamine Dose-response Tests for ACT, Other Coagulation Tests), Technology (Optical, Mechanical, Electrochemical) End User (Clinical Labs, Hospitals) and Regional Forecasts 2020-2027
Chapter 1. Executive Summary 1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion) 1.2.1. Coagulation Analyzer Market, by Region, 2018-2027 (USD Billion) 1.2.2. Coagulation Analyzer Market, by Product, 2018-2027 (USD Billion) 1.2.3. Coagulation Analyzer Market, by Test, 2018-2027 (USD Billion) 1.2.4. Coagulation Analyzer Market, by Technology, 2018-2027 (USD Billion) 1.2.5. Coagulation Analyzer Market, by End-user, 2018-2027 (USD Billion) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Coagulation Analyzer Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Coagulation Analyzer Market Dynamics 3.1. Coagulation Analyzer Market Impact Analysis (2018-2027) 3.1.1. Market Drivers 3.1.2. Market Challenges 3.1.3. Market Opportunities Chapter 4. Global Coagulation Analyzer Market Industry Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027) 4.2. PEST Analysis 4.2.1. Political 4.2.2. Economical 4.2.3. Social 4.2.4. Technological 4.3. Investment Adoption Model 4.4. Analyst Recommendation & Conclusion Chapter 5. Global Coagulation Analyzer Market, by Product 5.1. Market Snapshot 5.2. Global Coagulation Analyzer Market by Product, Performance - Potential Analysis 5.3. Global Coagulation Analyzer Market Estimates & Forecasts by Product 2017-2027 (USD Billion) 5.4. Coagulation Analyzer Market, Sub Segment Analysis 5.4.1. Clinical Laboratory Analyzers 5.4.2. Point-of-care-testing analyzers Chapter 6. Global Coagulation Analyzer Market, by Test 6.1. Market Snapshot 6.2. Global Coagulation Analyzer Market by Test, Performance - Potential Analysis 6.3. Global Coagulation Analyzer Market Estimates & Forecasts by Test 2017-2027 (USD Billion) 6.4. Coagulation Analyzer Market, Sub Segment Analysis 6.4.1. Prothrombin Time Testing (PT) 6.4.2. Fibrinogen 6.4.3. Activated Clotting Time Testing (ACT) 6.4.4. Activated Partial Thromboplastin Time Testing (APTT) 6.4.5. D Dimer 6.4.6. Platelet Function Tests 6.4.7. Anti-Factor XA Tests 6.4.8. Heparin & Protamine Dose-response Tests for ACT 6.4.9. Other Coagulation Tests Chapter 7. Global Coagulation Analyzer Market, by Technology 7.1. Market Snapshot 7.2. Global Coagulation Analyzer Market by Technology, Performance - Potential Analysis 7.3. Global Coagulation Analyzer Market Estimates & Forecasts by Technology 2017-2027 (USD Billion) 7.4. Coagulation Analyzer Market, Sub Segment Analysis 7.4.1. Optical 7.4.2. Mechanical 7.4.3. Electrochemical Chapter 8. Global Coagulation Analyzer Market, by End-User 8.1. Market Snapshot 8.2. Global Coagulation Analyzer Market by End-user, Performance - Potential Analysis 8.3. Global Coagulation Analyzer Market Estimates & Forecasts by End-User 2017-2027 (USD Billion) 8.4. Coagulation Analyzer Market, Sub Segment Analysis 8.4.1. Hospitals 8.4.2. Clinics Chapter 9. Global Coagulation Analyzer Market, Regional Analysis 9.1. Coagulation Analyzer Market, Regional Market Snapshot 9.2. North America Coagulation Analyzer Market 9.2.1. U.S. Coagulation Analyzer Market 184.108.40.206. Product breakdown estimates & forecasts, 2017-2027 220.127.116.11. Test breakdown estimates & forecasts, 2017-2027 18.104.22.168. Technology breakdown estimates & forecasts, 2017-2027 22.214.171.124. End-User breakdown estimates & forecasts, 2017-2027 9.2.2. Canada Coagulation Analyzer Market 9.3. Europe Coagulation Analyzer Market Snapshot 9.3.1. U.K. Coagulation Analyzer Market 9.3.2. Germany Coagulation Analyzer Market 9.3.3. France Coagulation Analyzer Market 9.3.4. Spain Coagulation Analyzer Market 9.3.5. Italy Coagulation Analyzer Market 9.3.6. Rest of Europe Coagulation Analyzer Market 9.4. Asia-Pacific Coagulation Analyzer Market Snapshot 9.4.1. China Coagulation Analyzer Market 9.4.2. India Coagulation Analyzer Market 9.4.3. Japan Coagulation Analyzer Market 9.4.4. Australia Coagulation Analyzer Market 9.4.5. South Korea Coagulation Analyzer Market 9.4.6. Rest of Asia Pacific Coagulation Analyzer Market 9.5. Latin America Coagulation Analyzer Market Snapshot 9.5.1. Brazil Coagulation Analyzer Market 9.5.2. Mexico Coagulation Analyzer Market 9.6. Rest of The World Coagulation Analyzer Market Chapter 10. Competitive Intelligence 10.1. Top Market Strategies 10.2. Company Profiles 10.2.1. Abbott Laboratories 10.2.1.1. Key Information 10.2.1.2. Overview 10.2.1.3. Financial (Subject to Data Availability) 10.2.1.4. Product Summary 10.2.1.5. Recent Developments 10.2.2. Danaher Corporation 10.2.3. Siemens Healthineers AG 10.2.4. Sysmex Corporation 10.2.5. Thermo Fisher Scientific Inc. 10.2.6. Horiba Ltd. 10.2.7. Nihon Kohden Corporation 10.2.8. Roche Diagnostics 10.2.9. Maccura Biotechnology Co. Ltd. 10.2.10. Bio Group Medical System Chapter 11. Research Process 11.1. Research Process 11.1.1. Data Mining 11.1.2. Analysis 11.1.3. Market Estimation 11.1.4. Validation 11.1.5. Publishing 11.2. Research Attributes 11.3. Research Assumption
Global Coagulation Analyzer Market is valued approximately USD 3.03 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.7 % over the forecast period 2020-2027. Coagulation Analyzers provide the measurement of blood platelet levels. The Clotting tests are used for hemostasis system diagnosis and new coagulometers are used to observe the expansion in blood plasma and blood clots in blood. Increasing incidences of blood clotting disorders along with Changing lifestyle which leads to factors such as Deficiency of Vitamin K, obesity, and smoking all lead to blood clotting resulting in demand for coagulation Analyzers. Further, increasing population base suffering from lifestyle associated disease, and chronic blood disorders and Cardiovascular diseases increase the demand for Coagulation Analyzers driving the market growth. As per the American Heart Association’s Circulation Journal Report Annual Statistics update issued in January 2019, 48% of the adults in the US have some form of CVD. Also, as per the European Heart network report 2017, Cardiovascular diseases cause 3.9 million deaths in Europe accounting for 45% of all the deaths. Also, rising awareness about these conditions is likely to expand the diagnostic rate and preventive care management, which is projected to substantially increase the testing volume driving the market growth. Furthermore, Growth in clinical laboratories and diagnostic centers have created a huge demand for coagulation analyzers market due to intensifying number of patients with blood clots. However, high cost and strict government regulations impedes the growth of the market over the forecast period of 2020-2027. Although, increased automation in the process presents a lucrative opportunity for the market.
The regional analysis of global Coagulation Analyzer market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growing number of clinics and hospitals along with well established healthcare infrastructure in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rising population and increasing prevalence of Cardiovascular and other chronic diseases would create lucrative growth prospects for the Coagulation Analyzer market across Asia-Pacific region.
Major market player included in this report are:
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Nihon Kohden Corporation
Maccura Biotechnology Co. Ltd.
Bio Group Medical System
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
Prothrombin Time Testing (PT)
Activated Clotting Time Testing (ACT)
Activated Partial Thromboplastin Time Testing (APTT)
Platelet Function Tests
Anti-Factor XA Tests
Heparin & Protamine Dose-response Tests for ACT
Other Coagulation Tests
By End User:
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of the Global Coagulation Analyzer Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers